SouthState Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.9K Sell
691
-398
-37% -$38.1K ﹤0.01% 438
2025
Q4
$105K Sell
1,089
-700
-39% -$68K ﹤0.01% 374
2025
Q3
$170K Sell
1,789
-107
-6% -$9.84K 0.01% 331
2025
Q2
$165K Buy
1,896
+561
+42% +$47.6K 0.01% 359
2025
Q1
$120K Buy
1,335
+772
+137% +$69.1K 0.01% 401
2024
Q4
$45K Sell
563
-200
-26% -$17.3K ﹤0.01% 367
2024
Q3
$68.7K Sell
763
-32
-4% -$2.69K ﹤0.01% 342
2024
Q2
$62.6K Buy
795
+60
+8% +$4.92K ﹤0.01% 351
2024
Q1
$64.1K Sell
735
-148
-17% -$12.6K 0.01% 352
2023
Q4
$72.7K Sell
883
-780
-47% -$59.4K 0.01% 319
2023
Q3
$130K Sell
1,663
-613
-27% -$51.3K 0.01% 267
2023
Q2
$201K Sell
2,276
-599
-21% -$51.6K 0.02% 243
2023
Q1
$232K Sell
2,875
-1,334
-32% -$109K 0.02% 243
2022
Q4
$327K Sell
4,209
-1,419
-25% -$115K 0.03% 218
2022
Q3
$454K Sell
5,628
-197
-3% -$17.7K 0.05% 194
2022
Q2
$523K Buy
5,825
+571
+11% +$57.9K 0.05% 188
2022
Q1
$583K Buy
5,254
+1,027
+24% +$109K 0.05% 194
2021
Q4
$437K Buy
4,227
+561
+15% +$65K 0.03% 206
2021
Q3
$460K Buy
3,666
+79
+2% +$10.2K 0.04% 191
2021
Q2
$445K Sell
3,587
-396
-10% -$49.7K 0.04% 196
2021
Q1
$471K Buy
3,983
+83
+2% +$9.73K 0.04% 192
2020
Q4
$457K Sell
3,900
-574
-13% -$63.2K 0.05% 188
2020
Q3
$465K Buy
4,474
+1,432
+47% +$144K 0.05% 180
2020
Q2
$279K Sell
3,042
-145
-5% -$13.9K 0.03% 195
2020
Q1
$287K Sell
3,187
-403
-11% -$42.9K 0.04% 188
2019
Q4
$407K Buy
3,590
+931
+35% +$102K 0.05% 188
2019
Q3
$289K Sell
2,659
-214
-7% -$22.3K 0.04% 203
2019
Q2
$280K Sell
2,873
-3,600
-56% -$329K 0.03% 219
2019
Q1
$590K Buy
6,473
+1,352
+26% +$121K 0.06% 180
2018
Q4
$466K Sell
5,121
-433
-8% -$40.5K 0.05% 190
2018
Q3
$546K Sell
5,554
-13,753
-71% -$1.27M 0.06% 185
2018
Q2
$1.65M Buy
19,307
+3,617
+23% +$302K 0.19% 111
2018
Q1
$1.26M Buy
15,690
+849
+6% +$70K 0.14% 128
2017
Q4
$1.2M Buy
14,841
+1,378
+10% +$110K 0.13% 138
2017
Q3
$1.05K Buy
13,463
+30
+0.2% +$2.49K 0.12% 132
2017
Q2
$1.19M Buy
13,433
+350
+3% +$29.5K 0.15% 122
2017
Q1
$1.05M Buy
13,083
+1,007
+8% +$78.7K 0.14% 132
2016
Q4
$860K Sell
12,076
-2,916
-19% -$229K 0.12% 139
2016
Q3
$1.29M Sell
14,992
-1,009
-6% -$87.9K 0.2% 113
2016
Q2
$1.39M Buy
16,001
+7,597
+90% +$614K 0.21% 111
2016
Q1
$630K Buy
8,404
+270
+3% +$20.3K 0.1% 141
2015
Q4
$625K Sell
8,134
-120
-1% -$9.03K 0.1% 140
2015
Q3
$553K Sell
8,254
-1,395
-14% -$103K 0.08% 157
2015
Q2
$715K Buy
9,649
+97
+1% +$7.41K 0.1% 149
2015
Q1
$746K Sell
9,552
-3,637
-28% -$276K 0.11% 152
2014
Q4
$952K Buy
13,189
+6,209
+89% +$431K 0.15% 134
2014
Q3
$432K Sell
6,980
-60
-0.9% -$3.81K 0.07% 190
2014
Q2
$449K Sell
7,040
-95
-1% -$5.77K 0.07% 170
2014
Q1
$439K Hold
7,135
0.07% 179
2013
Q4
$410K Buy
7,135
+85
+1% +$4.82K 0.07% 182
2013
Q3
$375K Buy
7,050
+1,400
+25% +$75.3K 0.07% 182
2013
Q2
$291K Buy
+5,650
New +$279K 0.06% 173

Other funds holding MDT

SouthState Corp's MDT Position: Q1 2026 in Review

SouthState Corp reduced its Medtronic (MDT) stake by 37% in Q1 2026, selling an estimated $38.1K and leaving 691 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #438.

SouthState Corp first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.65M in Q2 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • SouthState Corp held 691 shares of Medtronic worth $59.9K as of Q1 2026.
  • SouthState Corp sold 398 Medtronic shares in Q1 2026, an estimated $38.1K.
  • Medtronic made up ﹤0.01% of SouthState Corp's portfolio in Q1 2026, its #438 holding.
  • SouthState Corp first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • SouthState Corp's Medtronic position peaked at $1.65M in Q2 2018.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.